FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010993798> ?p ?o ?g. }

• W2010993798 endingPage "1075" @default.
• W2010993798 startingPage "1067" @default.
• W2010993798 abstract "The aim of this study was to delineate the temporal profile of adventitial microvessel (Ad-MV) formation after stenting, its relationship to arterial wall hypoxia, and the effects of a tyrosine kinase inhibitor (TKI), SU11218, on Ad-MV and in-stent intimal hyperplasia (IH).Adventitial microvessels have been reported after arterial injury; however, the underlying stimulus for this response and its relationship to IH is unknown.Coronary stenting was performed in 40 pigs randomized to SU11218 (n = 20) or placebo (n = 20). Vessel wall hypoxia was assessed by pimonidazole adducts and hypoxia-inducible factor (HIF)-1 alpha expression. Adventitial microvessels were quantified by three-dimensional microscopic computed tomography (3D micro CT). Intimal hyperplasia was measured by intravascular ultrasound (IVUS), 3D micro CT, and morphometry. The effects of SU11218 were assessed in vitro on smooth muscle cell (SMC) and endothelial cell (EC) functions and in vivo on Ad-MV and IH.Hypoxia was evident in the vessel wall at 48 h and persisted for four weeks. Adventitial microvessels increased significantly at one week (24 +/- 7 microvessels/segment) and four weeks (23 +/- 7 microvessels/segment) compared with uninjured arteries (16 +/- 2 microvessels/segment; p < 0.001) and correlated with IH (r = 0.77, p < 0.001). The TKI SU11218 inhibited platelet-derived growth factor receptor-beta phosphorylation, EC and SMC DNA synthesis, and migration in a dose-dependent manner in vitro and significantly inhibited Ad-MV (16 +/- 5 vs. 23 +/- 7 microvessels/segment in placebo, p < 0.001) and produced approximately 80% reduction in IH (0.52 +/- 0.51 mm2 vs. 2.47 +/- 1.66 mm2 in placebo, p < 0.001) at four weeks in vivo.Arterial stenting causes arterial wall hypoxia followed by Ad-MV formation. The TKI SU11218 inhibits both Ad-MV formation and IH and represents a promising therapeutic agent to prevent in-stent restenosis." @default.
• W2010993798 created "2016-06-24" @default.
• W2010993798 creator A5002221685 @default.
• W2010993798 creator A5028881980 @default.
• W2010993798 creator A5035999145 @default.
• W2010993798 creator A5046103186 @default.
• W2010993798 creator A5052765446 @default.
• W2010993798 creator A5059360994 @default.
• W2010993798 creator A5065359057 @default.
• W2010993798 creator A5068524141 @default.
• W2010993798 creator A5071162611 @default.
• W2010993798 creator A5071287538 @default.
• W2010993798 creator A5073316865 @default.
• W2010993798 creator A5085718584 @default.
• W2010993798 creator A5086273146 @default.
• W2010993798 creator A5087490596 @default.
• W2010993798 date "2006-03-01" @default.
• W2010993798 modified "2023-10-12" @default.
• W2010993798 title "Adventitial Microvessel Formation After Coronary Stenting and the Effects of SU11218, a Tyrosine Kinase Inhibitor" @default.
• W2010993798 cites W1434966346 @default.
• W2010993798 cites W1517718326 @default.
• W2010993798 cites W181093158 @default.
• W2010993798 cites W1965772932 @default.
• W2010993798 cites W1992487050 @default.
• W2010993798 cites W1997254182 @default.
• W2010993798 cites W2000000541 @default.
• W2010993798 cites W2004466315 @default.
• W2010993798 cites W2009883632 @default.
• W2010993798 cites W2010188924 @default.
• W2010993798 cites W2014434817 @default.
• W2010993798 cites W2014742445 @default.
• W2010993798 cites W2015344488 @default.
• W2010993798 cites W2055835375 @default.
• W2010993798 cites W2056242981 @default.
• W2010993798 cites W2067241300 @default.
• W2010993798 cites W2072998283 @default.
• W2010993798 cites W2074919956 @default.
• W2010993798 cites W2082578363 @default.
• W2010993798 cites W2085047441 @default.
• W2010993798 cites W2096719505 @default.
• W2010993798 cites W2104337891 @default.
• W2010993798 cites W2106993962 @default.
• W2010993798 cites W2112225171 @default.
• W2010993798 cites W2120582139 @default.
• W2010993798 cites W2125150769 @default.
• W2010993798 cites W2127507533 @default.
• W2010993798 cites W2138272188 @default.
• W2010993798 cites W2146672236 @default.
• W2010993798 cites W2152639592 @default.
• W2010993798 cites W2157812230 @default.
• W2010993798 cites W2172240949 @default.
• W2010993798 cites W36000590 @default.
• W2010993798 cites W4247506353 @default.
• W2010993798 cites W4251787912 @default.
• W2010993798 cites W4253705647 @default.
• W2010993798 doi "https://doi.org/10.1016/j.jacc.2005.08.076" @default.
• W2010993798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16516095" @default.
• W2010993798 hasPublicationYear "2006" @default.
• W2010993798 type Work @default.
• W2010993798 sameAs 2010993798 @default.
• W2010993798 citedByCount "37" @default.
• W2010993798 countsByYear W20109937982012 @default.
• W2010993798 countsByYear W20109937982013 @default.
• W2010993798 countsByYear W20109937982014 @default.
• W2010993798 countsByYear W20109937982015 @default.
• W2010993798 countsByYear W20109937982016 @default.
• W2010993798 countsByYear W20109937982017 @default.
• W2010993798 countsByYear W20109937982019 @default.
• W2010993798 countsByYear W20109937982020 @default.
• W2010993798 countsByYear W20109937982022 @default.
• W2010993798 crossrefType "journal-article" @default.
• W2010993798 hasAuthorship W2010993798A5002221685 @default.
• W2010993798 hasAuthorship W2010993798A5028881980 @default.
• W2010993798 hasAuthorship W2010993798A5035999145 @default.
• W2010993798 hasAuthorship W2010993798A5046103186 @default.
• W2010993798 hasAuthorship W2010993798A5052765446 @default.
• W2010993798 hasAuthorship W2010993798A5059360994 @default.
• W2010993798 hasAuthorship W2010993798A5065359057 @default.
• W2010993798 hasAuthorship W2010993798A5068524141 @default.
• W2010993798 hasAuthorship W2010993798A5071162611 @default.
• W2010993798 hasAuthorship W2010993798A5071287538 @default.
• W2010993798 hasAuthorship W2010993798A5073316865 @default.
• W2010993798 hasAuthorship W2010993798A5085718584 @default.
• W2010993798 hasAuthorship W2010993798A5086273146 @default.
• W2010993798 hasAuthorship W2010993798A5087490596 @default.
• W2010993798 hasConcept C126322002 @default.
• W2010993798 hasConcept C142724271 @default.
• W2010993798 hasConcept C178790620 @default.
• W2010993798 hasConcept C185592680 @default.
• W2010993798 hasConcept C2776436680 @default.
• W2010993798 hasConcept C2776820930 @default.
• W2010993798 hasConcept C2778742706 @default.
• W2010993798 hasConcept C2779751240 @default.
• W2010993798 hasConcept C2780394083 @default.
• W2010993798 hasConcept C2992686903 @default.
• W2010993798 hasConcept C540031477 @default.
• W2010993798 hasConcept C71924100 @default.
• W2010993798 hasConcept C7836513 @default.

• next